| Trial ID: | L0177 |
| Source ID: | NCT00068094
|
| Associated Drug: |
Probiotic
|
| Title: |
The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics
|
| Acronym: |
--
|
| Status: |
Terminated
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver|Hepatic Steatosis|Diabetes Mellitus|Liver Diseases
|
| Interventions: |
Drug: Probiotic-containing powder
|
| Outcome Measures: |
--
|
| Sponsor/Collaborators: |
National Center for Complementary and Integrative Health (NCCIH)
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 1/Phase 2
|
| Enrollment: |
30
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment
|
| Start Date: |
July 2005
|
| Completion Date: |
February 2006
|
| Results First Posted: |
--
|
| Last Update Posted: |
August 18, 2006
|
| Locations: |
Johns Hopkins University, Baltimore, Maryland, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT00068094
|
